Depression

Brain imaging, known as functional MRI, combined with machine learning can predict a treatment response based on one’s depression “biotype.”…

Professor of psychiatry and behavioral health Leanne Williams will lead a project to define depression’s cognitive biotypes and create tools for clinicians to diagnose and treat patients.

The new issue of Stanford Medicine magazine reports on emerging research and innovative treatments to improve mental health.

Stanford Medicine researchers find that ibogaine, a plant-based psychoactive compound, safely led to improvements in depression, anxiety and functioning among veterans with traumatic brain injuries.

In an unusual trial, Stanford Medicine researchers found that a patient’s belief that they had received ketamine, even if they didn’t, could improve their depression.

Scientists discover a biomarker in stroke survivors, suggesting that chemical changes after stroke can lead to depression. The findings may pave the way toward treatment.

Using surveys, cognitive tests and brain imaging, researchers have identified a type of depression that affects about a quarter of patients. The goal is to diagnose and treat the condition more precisely.

A new study led by Stanford Medicine researchers is the first to reveal how magnetic stimulation treats severe depression: by correcting the abnormal flow of brain signals.

In what authors believe to be the largest study of its kind, Stanford Medicine researchers found that impostor syndrome is more prevalent in physicians than in other U.S. workers.

In a double-blind controlled study, high doses of magnetic brain stimulation, given on an accelerated timeline and individually targeted, caused remission in 79% of trial participants with severe depression.

Stanford Medicine researchers used high doses of magnetic stimulation, delivered on an accelerated timeline and targeted to individual neurocircuitry, to treat patients with severe depression.